“CIEL has been instrumental in supporting our business activities.”
“Working with CIEL, we have submitted funding calls, heard about new technologies and met other interesting businesses and academics that we wouldn’t have done otherwise. I’d recommend joining CIEL to any new business looking to do R&D and scale up quickly.” Martyn, DraperBIOTECH
Member Case Study
Founded in 2015, Biotangents are developing on-farm diagnostics to detect nucleic acid signatures from pathogenic organisms. Using the patent-pending Moduleic Sensing™ platform technology, users can rapidly and accurately diagnose the presence of the pathogen, allowing effective management decisions to be made earlier and reducing further disease spread.